Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease
Buruli ulcer (BU) is a chronic necrotizing skin disease caused by Mycobacterium ulcerans. Historically, the disease was treated by surgical excision of the skin lesions, until an 8-week combination therapy of rifampicin and streptomycin was introduced in 2004. This treatment modality was effective...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Alemão |
| Publicado em: |
Swiss Chemical Society
2023-09-01
|
| coleção: | CHIMIA |
| Assuntos: | |
| Acesso em linha: | https://www.chimia.ch/chimia/article/view/7038 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|